Sight Diagnostics
About Sight Diagnostics
Sight Diagnostics is a healthcare AI company that specializes in developing and commercializing AI-powered blood diagnostic devices to provide rapid, lab-grade results. Their flagship product, OLO, is designed to perform a complete blood count (CBC) from just two drops of blood, obtained via a finger-prick or venous sample, delivering results within minutes. This technology utilizes digital fluorescent microscopy and computer vision algorithms to analyze blood samples, aiming to decentralize blood testing from central laboratories to various point-of-care settings such as doctors’ offices, emergency medical centers, and smaller clinics.
The company’s technology is built upon a foundation of advanced computer vision and machine learning, which was initially proven with their Parasight platform for malaria diagnosis. Sight OLO measures 19 different blood parameters, offering a five-part differential blood count. The system is designed for ease of use, requiring minimal training, no maintenance or calibration, and does not necessitate reagents or manual quality control tests, making it suitable for diverse clinical environments. Sight Diagnostics’ vision is to expand disease detection and improve patient outcomes through more accessible and efficient blood testing.
Focus Areas
Business Intelligence
| Technology | AI, machine vision, digital fluorescent microscopy, computer vision algorithms, proprietary algorithms, single-use test kits, dry instrument, Failsafe self-test system |
What Physicians Need to Know
Sight Diagnostics' OLO analyzer provides lab-accurate CBC results in minutes from a finger-prick or venous blood sample, allowing for fast, data-driven decisions and immediate patient treatment. [1, 2, 4, 8, 9] The device seamlessly integrates into existing workflows, requires no maintenance or calibration, and is simple to operate after minimal training. [2, 10] This decentralized approach to diagnostics can significantly improve patient outcomes by making essential testing more accessible and efficient, especially in settings without full laboratory capabilities. [1, 2, 5]
The OLO analyzer is designed to seamlessly integrate into existing provider workflows. [2] The company is actively expanding its commercial footprint and partnerships globally, including regulatory approvals in multiple countries and collaborations with local distributors and healthcare systems. [1, 5, 6, 14]
What the Web Says
Sight Diagnostics is a company specializing in rapid blood diagnostics using computer vision and machine learning. Their flagship product, OLO, performs complete blood count (CBC) tests from a finger prick sample, providing lab-grade results in minutes. The company also developed Parasight for malaria diagnosis. While praised for its innovative technology and ease of use, some concerns have been raised regarding its limited test categories and recent workforce reduction.
Overall: MixedStrengths
- Rapid and accurate lab-grade blood test results in minutes.
- Uses a small finger prick blood sample, eliminating the need for venous draws.
- OLO analyzer is small, sleek, intuitive, and easy to use with minimal training and no maintenance.
- Cost-effective for point-of-care testing, making it accessible for doctors' offices and smaller clinics.
- Parasight platform has been successfully used for malaria detection in numerous countries.
- Positive feedback on management and a great place to work from some employees.
Limitations
- OLO currently only runs one category of tests (hematology/CBC), meaning other machines and samples are still needed for comprehensive patient care.
- Concerns about the company's strategic direction and financial stability due to a 30% workforce reduction and a founder's departure in 2024.
- Some Reddit discussions draw parallels to Theranos due to the focus on a small, rapid testing device, though Sight Diagnostics has FDA approval and vetted products.
- Super high staff turnover reported by some employees.
- Areas for improvement in work happiness, ability to meet personal goals, and fair pay for the job cited by employees.
- Limited banking integrations for quick liquidations in their Audit Sight product (a different product, not OLO).
Based on reviews from: Indeed.com, Reddit, Canada Newswire, Forbes, Startup Nation Finder, DIA, NoCamels, MobiHealthNews, Capterra, G2
Last updated: 2026-10-19
Videos
News, demos, and interviews about Sight Diagnostics.
Videos load interactively. If none appear, search YouTube for Sight Diagnostics →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Sight Diagnostics.
Related Companies
AIRA Matrix is a healthcare AI company that develops cutting-edge artificial intelligence solutions for life sciences applications, with a strong emphasis on deep learning for medical image analysis. Their innovative products and services are designed to enhance diagnostic accuracy, improve workflow efficiency, and reduce turnaround times in pathology laboratories. The company provides diagnostic, prognostic, and […]
AI-LabTest is a secure, AI-powered digital health platform designed to help individuals understand their medical lab reports. The platform analyzes uploaded bloodwork or diagnostic results (in PDF, JPG, or TXT formats) and translates complex medical data into clear, personalized summaries. These summaries highlight key findings, potential implications, and practical next steps in patient-friendly language. The […]
Google DeepMind is a British-American artificial intelligence (AI) research laboratory and a subsidiary of Alphabet Inc.. Formed in April 2023 through the merger of DeepMind and Google AI’s Google Brain division, the company focuses on advancing artificial general intelligence (AGI) and developing AI systems for widespread public benefit and scientific discovery. Their work involves an […]
Tempus AI, Inc. is an American health technology company that utilizes data and artificial intelligence to deliver precision medicine services. The company was founded with the mission to bring data-driven precision medicine into routine care, initially focusing on oncology. Tempus has developed a platform that sequences tumor samples and employs AI models to assist physicians […]
LabLynx is a privately held American laboratory informatics company that specializes in developing, supporting, and marketing Laboratory Information Management System (LIMS) solutions. The company has a long history in the industry, having introduced one of the first browser-based LIMS products in 1997. LabLynx’s primary offerings include ELab LIMS, a configurable cloud-based LIMS that serves various […]
August AI is a healthcare artificial intelligence company that has developed an AI-powered digital health companion. This platform is designed to provide accessible medical care and health guidance, acting as a ‘health companion’ rather than a replacement for clinical visits. It assists users in understanding symptoms, interpreting medical reports, and managing ongoing treatment. The company’s […]